Deka Bank Deutsche Girozentrale Intra Cellular Therapies, Inc. Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 51,997 shares of ITCI stock, worth $4.46 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

51,997

Previous 52,499 0.96%

Holding current value

$4.46 Million

Previous $3.71 Million 2.32%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$67.99 - $80.84 $34,130 - $40,581	-502 Reduced 0.96%	51,997 $3.8 Million
Q2 2024 Aug 08, 2024	BUY	$64.76 - $79.84 $32,509 - $40,079	502 Added 0.97%	52,499 $3.71 Million
Q4 2023 Jan 24, 2024	BUY	$46.37 - $73.65 $510,070 - $810,150	11,000 Added 26.83%	51,997 $3.79 Million
Q3 2023 Nov 13, 2023	BUY	$52.09 - $64.1 $51,933 - $63,907	997 Added 2.49%	40,997 $2.19 Million
Q2 2023 Jul 25, 2023	BUY	$54.67 - $66.44 $273,350 - $332,200	5,000 Added 14.29%	40,000 $2.46 Million
Q4 2022 Feb 01, 2023	SELL	$44.07 - $54.45 $362,211 - $447,524	-8,219 Reduced 19.02%	35,000 $1.85 Million
Q3 2022 Nov 02, 2022	SELL	$42.7 - $59.99 $15,542 - $21,836	-364 Reduced 0.84%	43,219 $1.93 Million
Q2 2022 Aug 03, 2022	SELL	$43.0 - $65.64 $39,431 - $60,191	-917 Reduced 2.06%	43,583 $2.48 Million
Q1 2022 Apr 28, 2022	BUY	$38.74 - $62.09 $491,998 - $788,543	12,700 Added 39.94%	44,500 $2.72 Million
Q4 2021 Feb 02, 2022	BUY	$35.2 - $53.42 $31,680 - $48,078	900 Added 2.91%	31,800 $1.63 Million
Q4 2020 Mar 12, 2021	SELL	$23.34 - $32.22 $35,010 - $48,330	-1,500 Reduced 4.63%	30,900 $953,000
Q3 2020 Oct 29, 2020	BUY	$17.61 - $31.86 $570,564 - $1.03 Million	32,400 New	32,400 $811,000
Q4 2019 Feb 04, 2020	SELL	$7.26 - $38.49 $476,982 - $2.53 Million	-65,700 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$7.47 - $14.03 $490,779 - $921,771	-65,700 Reduced 50.0%	65,700 $493,000
Q2 2019 Aug 01, 2019	BUY	$10.65 - $14.29 $452,625 - $607,325	42,500 Added 47.81%	131,400 $1.67 Million
Q1 2019 May 10, 2019	BUY	$10.9 - $14.09 $100,280 - $129,628	9,200 Added 11.54%	88,900 $1.95 Million
Q4 2018 Feb 12, 2019	SELL	$10.36 - $20.96 $95,312 - $192,832	-9,200 Reduced 10.35%	79,700 $868,000
Q3 2018 Nov 09, 2018	BUY	$17.77 - $22.9 $225,679 - $290,830	12,700 Added 16.67%	88,900 $0
Q2 2018 Aug 14, 2018	SELL	$17.33 - $23.4 $2.37 Million - $3.21 Million	-137,000 Reduced 64.26%	76,200 $1.36 Million
Q1 2018 May 03, 2018	SELL	$15.16 - $25.49 $1.15 Million - $1.94 Million	-76,000 Reduced 26.28%	213,200 $4.39 Million
Q3 2017 Nov 06, 2017	BUY	$10.77 - $22.1 $3.11 Million - $6.39 Million	289,200	289,200 $3.35 Million

Others Institutions Holding ITCI

# of Institutions

377

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.09B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Intra Cellular Therapies, Inc. Transaction History